Viewing Study NCT06187506


Ignite Creation Date: 2025-12-26 @ 2:41 PM
Ignite Modification Date: 2025-12-26 @ 2:41 PM
Study NCT ID: NCT06187506
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2023-12-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module